Shanxi Zhendong Pharmaceutical (300158) — Cash Flow Quality Index
Shanxi Zhendong Pharmaceutical (300158) has a Cash Flow Quality Index of -15.92x as of September 2025. Operating cash flow of CN¥-197.94 Million is below net income of CN¥12.43 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how well can Shanxi Zhendong Pharmaceutical service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanxi Zhendong Pharmaceutical Cash Flow Quality Index (2007–2021)
Historical Cash Flow Quality Index for Shanxi Zhendong Pharmaceutical across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 300158 cash flow metrics.
Annual Cash Flow Quality Index for Shanxi Zhendong Pharmaceutical (2007–2021)
Year-by-year earnings quality comparison for Shanxi Zhendong Pharmaceutical.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 0.11x | CN¥284.45 Million | CN¥2.61 Billion | ▼ -87.5% |
| 2020 | 0.88x | CN¥221.94 Million | CN¥253.57 Million | ▼ -35.6% |
| 2019 | 1.36x | CN¥186.35 Million | CN¥137.04 Million | ▲ +776.1% |
| 2017 | 0.16x | CN¥45.09 Million | CN¥290.48 Million | ▲ +167.0% |
| 2016 | -0.23x | CN¥-44.72 Million | CN¥193.13 Million | ▼ -108.4% |
| 2015 | 2.75x | CN¥151.84 Million | CN¥55.17 Million | ▲ +29.8% |
| 2014 | 2.12x | CN¥73.23 Million | CN¥34.52 Million | ▲ +275.3% |
| 2013 | -1.21x | CN¥-75.04 Million | CN¥62.00 Million | ▼ -155.9% |
| 2012 | 2.17x | CN¥189.40 Million | CN¥87.47 Million | ▲ +386.2% |
| 2011 | -0.76x | CN¥-88.73 Million | CN¥117.29 Million | ▼ -315.5% |
| 2010 | 0.35x | CN¥32.40 Million | CN¥92.29 Million | ▼ -43.5% |
| 2009 | 0.62x | CN¥42.28 Million | CN¥68.05 Million | ▲ +11.2% |
| 2008 | 0.56x | CN¥33.18 Million | CN¥59.39 Million | ▼ -83.0% |
| 2007 | 3.28x | CN¥128.65 Million | CN¥39.17 Million | — |